Project Grant R56HD117869
Award Date 9/15/25
Completion Date 8/31/27
Dollars Obligated $1.3M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06510, USA
Similar Awards
- This $474,946 Project Grant awarded on February 1, 2025 by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a novel, multipurpose device for female-initiated, non-hormonal contraception. The key products to be delivered under this grant include: Design and prototyping of a dual-compartment vaginal device that enables women to administer a bioresponsive polymer fiber mat...
- This federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to study the determinants of postpartum contraception and inter-pregnancy intervals. The total award amount is $1,371,278.00, with a project period from March 1, 2025 to November 30, 2029. The key objectives of this research project are to examine patient, partner, and provider factors that...
- This federal Project Grant award, valued at $692,843.00 and provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of estrogen formulation and delivery route on skeletal outcomes in functional hypothalamic amenorrhea (FHA). The primary objectives of this 5-year research project at the University of Virginia are to...
- This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD), is funding a Phase 1 clinical trial to evaluate the safety and pharmacokinetics of a novel contraceptive and microbicidal vaginal gel developed by Yaso Therapeutics Incorporated. The $545,966 award supports the first-in-human clinical assessment of the "YASO-GEL" product, which contains the active ingredient polyphenylene carboxymethylene sodium salt (PPCM). In addition to...
- The National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), awarded a $518,754 project grant to Magee-Womens Research Institute and Foundation. The goal of this project is to develop a bioadhesive vaginal film that can provide sustained release of contraceptive and antiviral monoclonal antibodies for 3-7 days. The film is intended to offer women a discreet, low-cost, and convenient...
- The University of California, Los Angeles (UCLA) has been awarded a $791,294 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865). The grant, which runs from September 1, 2025 to July 31, 2030, will fund a follow-up study to an existing NIH-funded randomized controlled trial examining the effects of improved contraceptive access on women's health and well-being....
- This federal Project Grant award, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), is supporting research on the role of decidual extracellular vesicles in mediating placental insufficiency. The $654,671 award, which commenced on August 1, 2025 and is scheduled for completion by April 30, 2030, is being conducted by the awardee, Yale University. The key...
- This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate interventions for reducing barriers to contraceptive access in low-resource settings. The $110,901 grant, awarded on December 24, 2024, will support the University of North Carolina at Chapel Hill in conducting the following key activities: 1) estimating the...
- Hera Health Solutions Inc. received a $275,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program to develop a biodegradable contraceptive-releasing implant. The award aims to advance long-acting reversible contraception by creating an implant that delivers consistent hormone doses and does not require surgical removal. During the one-year period from May 1, 2023 to April 30, 2024, the company will characterize the drug delivery scaffold,...
- This Project Grant award, valued at $643,049.00, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports the development of a physiomimetic model of endometrioma, a type of endometriotic lesion, to study processes driving lesion initiation, ovarian stroma invasion, and persistence in a chronic inflammatory environment. The research aims to uncover...